GlassScriptPhysician profile
Noel M Graham
NPI 1457323149
$2,504.46
in general payments reported to CMS, 2019-2025
20 companies · $790 in 2025
The $790 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $140 · 2021: $388 · 2022: $326 · 2023: $375 · 2024: $288 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $586.97 | 2020-2025 | Dyanavel Xr, Quillivant, Onyda Xr |
| Corium, LLC | $389.61 | 2021-2025 | Azstarys |
| Cranial Technologies, INC | $272.01 | 2019-2025 | Doc Band |
| Pfizer INC. | $261.63 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $254.83 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $145.60 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $84.30 | 2021 | |
| Glaxosmithkline, LLC. | $83.11 | 2022-2025 | Pediarix, Bexsero, Rotarix |
| Collegium Pharmaceutical, INC. | $74.29 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $59.70 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $54.77 | 2020-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Teva Pharmaceuticals USA, INC. | $44.33 | 2022-2023 | |
| Seqirus USA INC | $42.86 | 2023-2024 | Flucelvax, Fluad Quadrivalent, Flucelvax Quadrivalent |
| Verrica Pharmaceuticals INC. | $39.47 | 2023-2025 | Ycanth |
| Ultragenyx Pharmaceutical INC. | $29.66 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $17.89 | 2021 | |
| Azurity Pharmaceuticals, INC. | $17.67 | 2025 | Alvesco |
| Neos Therapeutics, LP | $16.77 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.08 | 2025 | Relexxii |
| Novo Nordisk INC | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.